Insights: News Releases Kilpatrick Townsend’s Joseph R. Snyder Appointed to AIPPI’s Standing Committee on Pharma and Biotechnology

WALNUT CREEK (January 24)Kilpatrick Townsend & Stockton announced today that partner Joe Snyder was recently appointed to AIPPI’s Standing Committee on Pharma and Biotechnology.

The International Association for the Protection of Intellectual Property, known as AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), is the world’s leading International Organization dedicated to the development and improvement of laws for the protection of intellectual property.

AIPPI's Standing Committee on Pharma and Biotechnology monitors, comments and advises AIPPI on policy, regulatory and legal frameworks relating to intellectual property protection for pharmaceutical products and processes; diagnostic products; medical devices; and biotechnology (including plant varieties) and biological products. For more information, please click here.

Dr. Snyder is the Managing Partner of the Kilpatrick Townsend’s Walnut Creek office. He focuses his practice on patent prosecution and counseling, emphasizing patent drafting, patent procurement, client counseling and opinion writing, primarily in the chemical arts, biotechnology, life sciences and clean technology. Dr. Snyder represents U.S. and foreign companies, such as pharmaceutical companies, diagnostic laboratories, universities and start-ups in all areas of intellectual property counseling and protection.

Follow the firm on Twitter: @KTS_Law.


Related People

If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”